European equities traded in the US as American depositary receipts were rising on Wednesday morning, up 0.5% to 1,497.69 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by pharmaceutical company Addex Therapeutics (ADXN) and advertising company Criteo (CRTO), which rose 5.1% and 2% respectively.
They were followed by energy company Eni (E), up 1.4%.
The decliners from continental Europe were led by biotech companies Abivax (ABVX) and Evaxion (EVAX), which fell 2.9% and 2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma (VRNA) and biotech firm Bicycle Therapeutics (BCYC), which gained 4.8% and 3.9% respectively.
They were followed by biotech company Barinthus Biotherapeutics (BRNS), which added 2%.
The decliners from the UK and Ireland were led by biotech firms Akari Therapeutics (AKTX) and Autolus Therapeutics (AUTL), which dropped 3.5% and 3.2% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。